Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)

Clinical trial NCT01180153 · UNKNOWN

Trial details

NCT number: NCT01180153
Sponsor: Peking University Cancer Hospital & Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2010-08-01
Primary completion: 2012-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.